Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Apalutamide + Abiraterone Acetate plus Prednisone + Leuprolide with Stereotactic, Ultra-Hypofractionated Radiation in Very High-Risk Prostate Cancer: A Single-Arm, Phase 2 Study.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

A high-resolution dimeric structure reveals a critical role of α-helix 9 in apoptotic Bax pore assembly in the mitochondrial membrane.

bioRxiv : the preprint server for biology·2026
Same author

High-content imaging of primary chronic lymphocytic leukemia cells predicts patient cohorts with distinct cellular drug responses.

iScience·2026
Same author

Recurrent Grade I Parafalcine Meningioma: Management Challenges and Genomic Insights.

Cureus·2025
Same author

Transcriptomic Analysis of Localized High-risk Prostate Cancer Improves Prognostication and Identifies Benefit from Adding Docetaxel to Definitive Radiotherapy with Androgen Suppression in the NRG Oncology/RTOG 0521 Phase 3 Trial.

European urology oncology·2025
Same author

Predictors of treatment response and overall survival in patients with breast cancer brain metastases treated with stereotactic radiosurgery: a prospective study using the NeuroPoint Alliance SRS Registry.

Journal of neurosurgery·2025
Same journal

Intramedullary Spinal Cord Tumors.

Neurosurgery clinics of North America·2026
Same journal

Spinal Cord Deformities Associated with Intramedullary Spinal Cord Tumors.

Neurosurgery clinics of North America·2026
Same journal

Radiation Therapy for Spinal Cord Tumors.

Neurosurgery clinics of North America·2026
Same journal

Treatment Strategies of Intramedullary Spinal Cord Tumors.

Neurosurgery clinics of North America·2026
Same journal

Vascular Lesions of the Spinal Cord: Arteriovenous and Cavernous Malformations.

Neurosurgery clinics of North America·2026
Same journal

Hemangioblastomas of the Spinal Cord.

Neurosurgery clinics of North America·2026
See all related articles

Related Experiment Video

Updated: Jun 6, 2026

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells
10:01

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Published on: August 2, 2022

Radiotherapy for brain metastases.

Robert B Den1, David W Andrews

  • 1Department of Radiation Oncology, Thomas Jefferson University, 111 South 11th Street, Bodine Cancer Center, Philadelphia, PA 19107, USA.

Neurosurgery Clinics of North America
|November 27, 2010
PubMed
Summary
This summary is machine-generated.

Brain metastases, the most common brain tumor, affect many cancer patients. Optimal treatment involves considering patient and tumor factors, with radiotherapy showing evidence in multiple strategies.

More Related Videos

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
08:54

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Published on: May 8, 2018

PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator
10:48

PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator

Published on: December 28, 2017

Related Experiment Videos

Last Updated: Jun 6, 2026

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells
10:01

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Published on: August 2, 2022

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
08:54

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Published on: May 8, 2018

PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator
10:48

PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator

Published on: December 28, 2017

Area of Science:

  • Neuro-oncology
  • Cancer Metastasis
  • Radiotherapy

Background:

  • Brain metastases are common in cancer patients, representing the most frequent intracranial tumor in adults.
  • The optimal management strategy for brain metastases is not definitively established and remains a subject of clinical debate.
  • Treatment decisions require careful consideration of individual patient characteristics and specific treatment-related factors.

Purpose of the Study:

  • To review the current landscape of treatment strategies for brain metastases.
  • To highlight the factors influencing the optimal management of intracranial tumors secondary to systemic cancer.
  • To summarize the existing evidence for radiotherapy in treating brain metastases.

Main Methods:

  • Review of existing clinical evidence and randomized controlled trials.
  • Analysis of patient- and treatment-related factors impacting management decisions.
  • Synthesis of current therapeutic approaches for brain metastases.

Main Results:

  • Brain metastases are a significant clinical challenge, affecting 20% to 40% of cancer patients.
  • Multiple treatment modalities exist, but optimal selection is individualized.
  • Randomized controlled evidence supports various radiotherapy-based treatment strategies.

Conclusions:

  • The management of brain metastases necessitates a personalized approach.
  • Radiotherapy is a cornerstone treatment with evidence supporting its efficacy in diverse strategies.
  • Further research may clarify optimal sequencing and combination therapies for improved patient outcomes.